SnugDock: Paratope Structural Optimization during Antibody-Antigen Docking Compensates for Errors in Antibody Homology Models by Sircar, Aroop & Gray, Jeffrey J.
SnugDock: Paratope Structural Optimization during
Antibody-Antigen Docking Compensates for Errors in
Antibody Homology Models
Aroop Sircar
1, Jeffrey J. Gray
1,2*
1Chemical & Biomolecular Engineering, Johns Hopkins University, Baltimore, Maryland, United States of America, 2Program in Molecular & Computational Biophysics,
Johns Hopkins University, Baltimore, Maryland, United States of America
Abstract
High resolution structures of antibody-antigen complexes are useful for analyzing the binding interface and to make
rational choices for antibody engineering. When a crystallographic structure of a complex is unavailable, the structure must
be predicted using computational tools. In this work, we illustrate a novel approach, named SnugDock, to predict high-
resolution antibody-antigen complex structures by simultaneously structurally optimizing the antibody-antigen rigid-body
positions, the relative orientation of the antibody light and heavy chains, and the conformations of the six complementarity
determining region loops. This approach is especially useful when the crystal structure of the antibody is not available,
requiring allowances for inaccuracies in an antibody homology model which would otherwise frustrate rigid-backbone
docking predictions. Local docking using SnugDock with the lowest-energy RosettaAntibody homology model produced
more accurate predictions than standard rigid-body docking. SnugDock can be combined with ensemble docking to mimic
conformer selection and induced fit resulting in increased sampling of diverse antibody conformations. The combined
algorithm produced four medium (Critical Assessment of PRediction of Interactions-CAPRI rating) and seven acceptable
lowest-interface-energy predictions in a test set of fifteen complexes. Structural analysis shows that diverse paratope
conformations are sampled, but docked paratope backbones are not necessarily closer to the crystal structure
conformations than the starting homology models. The accuracy of SnugDock predictions suggests a new genre of general
docking algorithms with flexible binding interfaces targeted towards making homology models useful for further high-
resolution predictions.
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Introduction
High resolution structures of protein-protein complexes are
necessary for understanding mechanisms of protein-protein
interactions, analyzing mutations, and manipulating binding
affinity [1]. The large gap between the number of experimentally
determined complex structures and the available sequences of
pairs of protein complexes underscores the challenges, time
required and cost of x-ray crystallography or nuclear magnetic
resonance approaches. The paucity in complex structures can be
alleviated by computational docking, i.e., the prediction of protein-
protein complexes, which potentially provides a fast and efficient
alternative route. To predict the structure of a protein-protein
complex, computational docking requires the structures of the
interacting partners. However, sometimes even the structures of
the monomeric units are unavailable, forcing the use of a
homology modeled structure for one or both partners [2,3].
Given the inaccuracies in a homology model, current computa-
tional docking strategies can determine the gross structural
features of a complex, but find it exceedingly challenging to
successfully predict high resolution structures of such protein-
protein complexes, pointing to the need to develop new docking
algorithms which incorporate the necessary degrees of freedom to
compensate for the inaccuracies.
Antibody-antigen (Ab-Ag) complexes provide a model system
where much needed high-resolution computational docking
predictions are challenged by inaccuracies in antibody homology
models. The selection of antibodies for exploring homology
model docking simplifies the problem by isolating the various
degrees of freedom according to prior knowledge of the
uncertainties in an antibody homology model, namely the
conformation of the complementarity determining region
(CDR) loops (L1, L2, L3 in the light chain, and H1, H2, H3 in
the heavy) [4,5], the hyper-variability of the CDR-H3 loop [6–9],
and the relative orientation of the antibody light (VL) and heavy
(VH) chains [6,10–12]. A recent study by Narayanan et al found
that the VL-VH relative orientation has a significant impact on
the antigen binding properties of an antibody [10], suggesting
that simultaneous optimization of the VL-VH relative orientation
and antibody-antigen relative orientation might capture some of
the intramolecular changes undergone by an antibody upon
antigen binding.
An additional motivation for studying antibody-antigen com-
plexes is that therapeutic antibodies are revolutionizing healthcare
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treatments have benefitted from newly developed therapeutic
antibodies [14]. Success of several therapeutic antibody drugs has
relied on homology modeling. According to Schwede et al.,
homology modeling played an important role in the development
of 11 of the first 21 marketed antibodies including Zenapax
(humanized anti-Tac or daclizumab), Herceptin (humanized anti-
HER2 or trastuzumab), and Avastin (humanized anti-VEGF or
bevacizumab) [15]. High-resolution computational docking can
aid in the design of antibody biologics by providing insights into
the complex interactions between an antibody and an antigen
[16]. The importance of antibodies combined with the detailed
knowledge of the flexibility in the various segments of an antibody
fragment variable (FV) region make them ideal candidates for the
development of novel flexible docking algorithms.
Although there are currently no flexible docking algorithms
tailored forantibodies, therehavebeenseveral effortstoincorporate
some of the relevant modes of internal flexibility during docking.
Early [17,18] and more recent approaches [19] use hinges to
account for internal flexibility. Multi-body docking, which might be
useful for optimizing assembly of VL and VH and antigen chains,
has been explored in a few case studies [20,21] including some
targets in the blind prediction challenge known as the Critical
Assessment of PRediction of Interactions (CAPRI) [22]. Another
genre of docking algorithms like HADDOCK [23] allows flexibility
in the side chains and backbones to allow for conformational
rearrangements in the interaction surface. Wang et al.’s modifica-
tions to RosettaDock allow simultaneous gradient-based minimiza-
tion of the backbone torsional angles and the protein-protein rigid-
body orientation [24]. We recently developed a RosettaDock
generalization called EnsembleDock [25] that follows the conform-
er-selection plus induced-fit model [26] to additionally enable
docking of a pre-generated ensemble of structures.
We also recently developed RosettaAntibody [27], an antibody
FV region homology modeling protocol which incorporates
refinement of VL-VH relative orientation, CDR H3 loop modeling
and minimization of all the CDR loops. RosettaAntibody
generates ten antibody homology models for each input sequence,
and this set of models can be used simultaneously with
EnsembleDock. However, errors in the CDRs of RosettaAntibody
homology models (particularly H2 and H3) can still frustrate
docking, and only the ten pre-generated backbone conformations
are sampled during ensemble docking [27].
In this paper, we discuss the development and implementation
of SnugDock, a new antibody docking algorithm built upon
RosettaDock using the sampling components of RosettaAntibody.
The new protocol performs multi-body docking by allowing
simultaneous structural optimization of the relative orientations of
antibody-antigen and VL-VH. SnugDock simulates induced fit by
additional simultaneous optimization of the binding interface by
allowing flexibility of CDR loops and interfacial side chains.
Moreover, we combine SnugDock with EnsembleDock to
synthesize a new docking algorithm that encompasses conformer
selection, multi-body docking, and a flexible paratope. We test
SnugDock using antibody homology models obtained from two
accessible public servers, namely RosettaAntibody [28] and Web
Antibody Modeling (WAM) [29]. Our goal is to achieve reliable
high-resolution antibody docking starting from only the antigen
unbound structure and the antibody sequence.
Results/Discussion
Figure 1 summarizes the SnugDock algorithm as incorporated
in RosettaDock. Like RosettaDock, SnugDock is divided into a
low-resolution and high-resolution stage. In the low-resolution
phase (shown in shades of green), SnugDock adds to RosettaDock
by additionally perturbing and minimizing the CDR H2 and H3
loops. In each iteration of the high-resolution Monte Carlo-plus-
minimization loop (shown in shades of blue), SnugDock randomly
chooses a trial move from a set including the various degrees of
freedom in both the antibody conformation space and the docking
space. Specifically, the trial move set consists of: i,ii) RosettaDock-
like rigid body transformations and minimization of either the
antibody-antigen or the VL-VH orientation; iii) gradient-based
minimization of the CDRs L1, L2, L3 and H1 backbones; and
iv,v) perturbation and minimization of the backbones of CDRs H2
or H3. The high-resolution iterations also include side-chain
rotamer packing steps before each minimization and Monte Carlo
Boltzmann acceptance decision (see Methods).
For various tests of the docking algorithm, we input either the
crystal structure of the antibody, the lowest-energy (lowest-scoring)
RosettaAntibody homology model, the ensemble of the ten lowest-
energy RosettaAntibody homology models, or the WAM model.
The antibody is docked to the unbound crystal structure of the
antigen when available. In the following sections, we first detail the
results of a case study as we build up the algorithm, then we
summarize the performance of different algorithms on the whole
set of antibodies. Next, we delve into the structural details of the
sampling. Finally we summarize the results starting from WAM
antibody models and the results of global docking.
Case study: effect of adding internal degrees of freedom
in homology model docking
Assessment criteria. A docking algorithm can be evaluated
by examining plots of a score (an approximation of free energy)
versus a measure of distance from the native co-crystal structure
for a set of candidate predicted structures. Since protein-protein
complexes are presumed to be at equilibrium, the lowest-energy
structures generated should match the native structure. Local
docking runs, which are typically used to evaluate the ability of an
algorithm to refine positions, refine a set of structures near the
native complex conformation. In this case, starting positions were
Author Summary
Antibodies are proteins that are key elements of the
immune system and increasingly used as drugs. Antibodies
bind tightly and specifically to antigens to block their
activity or to mark them for destruction. Three-dimensional
structures of the antibody-antigen complexes are useful
for understanding their mechanism and for designing
improved antibody drugs. Experimental determination of
structures is laborious and not always possible, so we have
developed tools to predict structures of antibody-antigen
complexes computationally. Computer-predicted models
of antibodies, or homology models, typically have errors
which can frustrate algorithms for prediction of protein-
protein interfaces (docking), and result in incorrect
predictions. Here, we have created and tested a new
docking algorithm which incorporates flexibility to over-
come structural errors in the antibody structural model.
The algorithm allows both intramolecular and interfacial
flexibility in the antibody during docking, resulting in
improved accuracy approaching that when using experi-
mentally determined antibody structures. Structural anal-
ysis of the predicted binding region of the complex will
enable the protein engineer to make rational choices for
better antibody drug designs.
Paratope Optimized Antibody-Antigen Docking
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and a spin around the axis of centers of the two proteins (0–360u).
Local docking is useful when epitope information is known, as is
common in many antibody applications [30–32].
Figure 2 shows plots that summarize local docking runs for
antibody 11k2 which binds human monocyte chemoattractant
protein (MCP)-1 [Protein Data Bank (PDB) ID code 2BDN [33]].
Due to difficulties in accurately capturing the energetic differences
from small backbone changes in flexible backbone docking, the
interface score (intermolecular energy) provides the best discrim-
ination of structures [24,25]. For a distance measure, we use the
ligand root mean square deviation (rmsd), defined as the rmsd of
the antigen N, Ca, C and O backbone atom coordinates in the
predicted structure relative to that in the native crystal structure of
the complex after superposition of the antibody N, Ca, C and O
backbone atom coordinates. Candidate structures, or decoys, are
rated according to the CAPRI assessment system as high quality,
medium quality, acceptable or incorrect based on a combination
of the ligand and interface rmsd and the fraction of correct
residue-residue contacts (fnat) across the interface [34]. To test the
convergence of a simulation to a correct solution, we define an
‘‘energy funnel’’ to exist when at least five of the ten lowest-energy
docking structures are of medium or high quality.
Docking with a single antibody homology model. In
Figure 2A, docking with standard RosettaDock (fixed backbones
and minimization of rotameric side chains [35,36]) using crystal
structures results in the best possible structural prediction of the
antibody-antigen complex and serves as the ‘‘gold standard’’ for
judging the docking with homology models. The lowest interface-
energy decoy is of medium quality, but since there are only four
medium quality decoys in the ten lowest interface-energy decoys, a
docking energy funnel is not formed.
We wish to compare the docking results when using an antibody
homology model. In a blind prediction, RosettaAntibody [27]
creates a lowest-energy model of the 11k2 antibody [33] with a
3.1 A ˚ CDR H3 global rmsd-to-native, 1.3 A ˚ rmsd-to-native for all
the CDRs, 2.5 A ˚ rmsd-to-native for the relative VL-VH orienta-
tion, and 1.4 A ˚ rmsd-to-native considering the entire FV.
Figures 2B–E show sample energy landscapes obtained by docking
simulations starting with the lowest-energy RosettaAntibody
homology model with the different protocols.
When the lowest-energy RosettaAntibody homology model is
docked using standard RosettaDock (Figure 2B), medium and
acceptable quality decoys are sampled, but the lowest interface-
energy decoy is incorrect, and there is only one medium quality
decoy in the ten lowest interface-energy predictions. The poor
scores of the medium quality decoys of these native-like structures
arise from steric clashes due to the fixed backbone conformation.
When clashes are relieved by moving the antigen away from the
bound configuration, docking prediction accuracy is lost.
To test the relative importance of the various degrees of
freedom in an antibody homology model, we built the SnugDock
Figure 1. SnugDock flowchart. The low and high resolution stages are shown in shades of green and blue respectively. The Move Set box
illustrates five different trial perturbations which are chosen randomly with indicated frequencies. *Rigid body positions are minimized corresponding
to the rigid body perturbation move selected. If all the CDRs are selected (see Move Set), they are minimized. If CDRs H3 or H2 are selected for
perturbation, they are not subjected to additional minimization since they are already minimized.
doi:10.1371/journal.pcbi.1000644.g001
Paratope Optimized Antibody-Antigen Docking
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Figure 2C shows the effect of docking the lowest-energy
RosettaAntibody model with a docking algorithm that perturbs
and minimizes the relative orientation of both the VL-VH and the
antibody-antigen pairs. Although the lowest interface-energy
decoy is still incorrect, the score difference between the lowest-
interface-energy incorrect decoys and lowest-interface-energy
acceptable quality decoys has been reduced. There are one
medium and two acceptable quality decoys in the ten lowest
interface-energy decoys. The interface scores produced by this run
are higher than those in the standard RosettaDock run. The
additional degrees of freedom allow lower total scores to be
accessed, but those lower scores are achieved at the expense of the
interface. That is, VH-VL interactions and some intra-chain
energies are improved, but the Ab-Ag interaction suffers.
Additional types of sampling are necessary to recover a low-
energy interface.
Following the incorporation of the VL-VH optimization, we
added CDR minimization along with explicit perturbations to the
CDR H3 loop conformation (Figure 2D). The lowest interface-
energy decoy is now a medium quality prediction, but since there
are only two medium quality predictions in the ten lowest
interface-energy decoys, an energy funnel is still absent.
Based on findings in our previous work in antibody-antigen
binding [27], that in some cases CDR H2 played a key role and had
the highest deviation from crystal structures amongst the grafted
CDRs, in the final step we added explicit perturbations to the CDR
H2 loop. The explicit perturbation of the CDR loops H2 and H3
combined with the minimization of all CDR loops, rigid body
optimization of the relative VL-VH orientation, and simultaneous
docking of the antigen results in the synthesis of a docking algorithm
with complete paratope optimization. With the full set of antibody
degrees of freedom, we call this implementation SnugDock. With
SnugDock the lowest interface-energy structure is of acceptable
quality (Figure 2E). This structure has a high ligand rmsd of 8.9 A ˚
and an interface rmsd of 4.2 A ˚ butstill meets the CAPRI acceptable
criteriabecausethefractionofnative residue-residuecontacts(fnat)is
39%, greater than the threshold of 30%. The fourth decoy is of
medium quality, with ligand rmsd of 6.6 A ˚, interface rmsd of 3.5 A ˚
and fnat of 55%, surpassing the stringent cutoff of 50%. There is one
additional medium and acceptable quality prediction in the ten
lowest interface-energy decoys.
Ensemble methods. Our previous work demonstrated that
using EnsembleDock with ten RosettaAntibody homology FV
models results in more accurate docking predictions than possible
by standard RosettaDock [27]. For a docking run with
EnsembleDock, the lowest interface-energy decoy is acceptable
quality (Figure 2F). In the ten lowest interface-energy decoys there
are four medium quality predictions.
Finally, we have combined SnugDock and EnsembleDock by
using all of the previous antibody sampling steps in addition to a
conformer-selection step that samples from ten pre-generated
RosettaAntibody models (Figure 2G). With the combined
algorithm, the lowest interface-energy decoy is of medium
accuracy and is better than the lowest interface-energy decoys of
both the independent SnugDock (Figure 2E) and EnsembleDock
(Figure 2F) simulations. The EnsembleDock-plus-SnugDock
approach results in five medium quality decoys in the ten lowest
interface-energy decoys, giving rise to a docking energy funnel and
suggesting that the combined algorithm is more robust. The lowest
interface-energy decoy generated by the combined protocol scores
lower than the lowest-energy decoy of the independent simula-
tions. The synergy demonstrated by the combined algorithm arises
from EnsembleDock sampling the backbone space more broadly
and SnugDock refining the antibody-antigen interface.
Benchmark set comparison of algorithms. While the
2BDN case demonstrates the type of analysis we use to evaluate
differing algorithms, it is necessary to consider a broader set of
targets to draw general conclusions. We identified 15 antibodies
with known complex structures and H3 loop lengths between 7
and 11 residues, the range where loop structure prediction is of
medium accuracy [27,37]. The full set of local docking plots for all
algorithm variants and all fifteen targets is in Supporting
Information Figure S1. Table 1 shows the CAPRI rating of the
lowest interface-energy model for each of the fifteen targets and
presents the three metrics of docking accuracy as each additional
degree of freedom is incorporated into the algorithm. The statistics
are summarized in a histogram in Figure 3.
Figure 2. Docking perturbation plots for blocking antibody 11k2 complexed with human monocyte chemoattractant protein
(MCP)-1 (2BDN [33]). (A) Standard rigid-body docking using RosettaDock starting with the antibody crystal structure. The red point represents the
native crystal structure. (B) Standard rigid-body docking using RosettaDock with the lowest-energy RosettaAntibody model. (C) Docking with VL-VH
optimization using the lowest-energy RosettaAntibody model. (D) Docking with VL-VH optimization with CDR minimization and CDR H3 perturbation
using the lowest-energy RosettaAntibody model. (E) Docking with SnugDock (VL-VH optimization with CDR minimization and CDR H3+H2
perturbations) using the lowest-energy RosettaAntibody model. (F) Rigid-body docking using EnsembleDock with the ten lowest-energy
RosettaAntibody models. (G) Docking using a combined protocol incorporating EnsembleDock and SnugDock with the ten lowest-energy
RosettaAntibody models.
doi:10.1371/journal.pcbi.1000644.g002
Paratope Optimized Antibody-Antigen Docking
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PLoS Computational Biology | www.ploscompbiol.org 5 January 2010 | Volume 6 | Issue 1 | e1000644The gold standard of docking crystal structures with standard
RosettaDock results in three and eight targets with lowest
interface-energy structures of high and medium quality, respec-
tively, and seven targets with funnels. However, when antibody
homology models are used as inputs to standard RosettaDock, the
successes fall to one medium and one acceptable quality result and
no funnels. As the degrees of freedom are added towards building
the SnugDock protocol, the number of successful predictions
increases. Homology model docking using the combination
EnsembleDock-plus-SnugDock protocol has similar number of
targets with acceptable or better predictions as the use of crystal
docking with standard RosettaDock, but the quality of docking
predictions is still much better for simulations starting with the
antibody crystal structure. Evaluation of docking protocols by a
looser criterion involving analysis of the most native-like decoy in
the ten lowest interface-energy predictions (Table 1; Figure 3B)
shows that, irrespective of the chosen protocol, a prediction of at
least an acceptable quality is obtained for most targets. The
number of docking funnels produced by each protocol also
increases steadily with the incorporation of additional degrees of
freedom (Table 1; Figure 3C), indicating that for local docking
with homology models any flexible docking protocol is better than
standard rigid-body docking.
In general, the results demonstrate that targeted flexibility in the
antibody can overcome the inaccuracies inherent in a homology
model and result in higher docking accuracy. The five energy
funnels produced by the full SnugDock algorithm and the seven
funnels produced by the EnsembleDock-plus-SnugDock protocol
suggest more confident and robust predictions since more low-
interface-energy decoys are native-like. Despite the general trends,
results vary by individual target. For example, for 2BDN or 2B2X,
accuracy improves as more degrees of freedom are used. But in
other targets, such as 1MLC or 2AEP, some steps result in
decreased performance.
The improvements in the prediction accuracy of antibody-antigen
complex structures are achieved at a computational cost. The
penultimate row of Table 1 shows the average total time required by
a single-core 2.33 GHz CPU to generate a result for one target. The
last row of Table 1 shows the effective simulation time, relative to
standard RosettaDock, required for each algorithm to create a single
candidatestructure.ThefullEnsembleDock-plus-SnugDockprotocol
requires 300 CPU-hours per prediction, roughly three times more
expensive than standard rigid-body RosettaDock.
High-resolution analysis of SnugDock decoys
Structural diversity generated by SnugDock. A major
objective of this study was to generate structural diversity in the
backbone to compensate for errors in the antibody homology
model. Figures 4A–B show side and top views of a set of models for
a representative target to show the structural diversity generated
by SnugDock or the EnsembleDock-SnugDock combination. The
diversity of the light chain framework (yellow) arises from the
SnugDock VL-VH rigid-body perturbation. With SnugDock alone,
the CDR loops (other than H2 and H3) have small variations from
the minimization steps. The structural diversity of the CDR H3
(grey) and H2 (cyan) is significantly broader, reflecting the
additional sampling by explicit w-y perturbations. Note the
discrepancy between the native CDR H3 conformation (red)
and the models (grey). With EnsembleDock-plus-SnugDock, CDR
H3 structures (green) spread more broadly, thus the combined
algorithm samples more diverse conformations than possible by
SnugDock alone. The gap between the native CDR H3
conformation and the SnugDock generated CDR H3
conformations is partially bridged by the EnsembleDock-plus-
SnugDock generated CDR H3 conformations.
The generated diversity is summarized quantitatively in
Figure 4C. CDRs that have been subjected to minimization only,
viz. CDRs L1, L2, L3 and H1, exhibit a mean divergence of less
than 0.1 A ˚ rmsd from the starting structure. CDRs H2 and H3,
which are subjected to explicit perturbation, sample a larger
conformational space and show a mean fluctuation of about 0.3 A ˚
rmsd from the starting structure. The relative VL-VH orientation,
which is subjected to rigid body moves followed by minimization,
also exhibits a similar divergence. The paratope as a whole,
Figure 3. Summary of docking performance. The bar plots show the number of correctly docked targets out of fifteen targets for different
docking algorithms. (A) Docking performance considering the lowest-energy decoy. (B) Docking performance considering the most native-like
prediction in the ten lowest-energy decoys. (C) Docking performance based on the presence of docking energy funnels. Crystal indicates standard
rigid-body docking using crystal structures. RosettaAntibody indicates standard rigid-body docking using RosettaDock starting with the lowest-energy
RosettaAntibody homology model. VL-VH indicates docking with VL-VH optimization. VL-VH+CDR H3 indicates docking with VL-VH optimization with
CDR minimization and CDR H3 perturbation. SnugDock indicates docking using SnugDock. Rigid Body Ensemble indicates rigid-body docking using
EnsembleDock with the ten lowest-energy RosettaAntibody homology models. Snug+Ensemble indicates docking using the EnsembleDock-plus-
SnugDock combined protocol with the ten lowest-energy RosettaAntibody homology models.
doi:10.1371/journal.pcbi.1000644.g003
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PLoS Computational Biology | www.ploscompbiol.org 6 January 2010 | Volume 6 | Issue 1 | e1000644influenced by both the loop conformations and the relative
orientation of the heavy and the light chains, has a mean rmsd of
0.3 A ˚ to the starting structure. These deviations enable the antibody
to sample lower energy conformations, but are not typically large
enough to capture the full transition from the homology model to
the bound conformation. Homology modeled CDR H3s, for
example are typically 1–3 A ˚ away from the bound conformation,
and this range is similar to the diversity of conformations of low-
energy antibody models used in EnsembleDock.
Successes: paratope optimization can help recover native-
like decoys. Figure 5 shows the interface of the complex
structure formed by Fab D44.1 and lysozyme (1MLC [38]).
Aligning the lowest-energy RosettaAntibody FV homology model
with the bound crystal conformation of the antibody in the crystal
complex gives rise to clashes with the bound conformation of the
antigen (Figure 5A). Specifically, antigen residues Arg-45, Thr-47
and Arg-68 clash with antibody residues Tyr-58H (in CDR H2),
Asn-92L(L3)and Asp-96H(H3)respectively.Theclashesarisefrom
the structural deviation in the loops: global rmsd-to-native of CDRs
L3,H2andH3ofthe FVhomologymodelis0.7 A ˚, 1.0 A ˚ and 1.9 A ˚
respectively. After docking with standard RosettaDock, the most
native-like decoy in the ten lowest interface-energy docking
solutions does not have any clashes (Figure 5B), but the antigen
(red) is displaced from its bound orientation (green) resulting in an
acceptable quality model. After the paratope is altered by
SnugDock, the CDRs H3 and L3 have similar global rmsd, and
CDR H2 moves slightly closer to the native. SnugDock relieves the
clashes while keeping the antigen (grey) close to the bound
conformation (green), resulting in a medium quality model
(Figure 5C). The paratope, comprising all the CDR loops in the
SnugDock generated model (Figure 5C), is 0.1 A ˚ rmsd closer to the
bound crystal conformation than that of the starting structure. A
superposition of the structures predicted by standard RosettaDock
and SnugDock (Figure 5D) shows that the antigen orientation
predicted by standard RosettaDock is rotated by ,25u compared to
the crystal structure, whereas the antigen orientation predicted by
SnugDock is very close to the native orientation. This example is
typical of those for which SnugDock improves docking. SnugDock
allows the antibody to find a way to fit without clashes, but does not
necessarily move the antibody’s internal conformation closer to its
native bound backbone structure.
Failures: dangers of over-optimizing the binding
interface. The docking accuracy of EnsembleDock-plus-
SnugDock is typically equal or better than using EnsembleDock
alone. One exception is the complex of west Nile virus envelope
protein DIII with neutralizing E16 antibody Fab (1ZTX [39]).
EnsembleDock produces a high-quality top-ranked structure
whereas EnsembleDock-plus-SnugDock produces only an
acceptable accuracy structure. Interestingly, if the EnsembleDock-
plus-SnugDock decoys for target 1ZTX are sorted by the score of
the entire complex instead of the interface score, the lowest energy
decoy is of medium quality and a docking funnel is formed. The
lowest total-energy decoy has a CDR H3 global rmsd of 1.7 A ˚,
whereas the lowest interface-energy decoy has a CDR H3 global
rmsd of 2.7 A ˚. The 1.7 A ˚ CDR H3 loop model has a poorly packed
interface with voids, penalizing the interface score (Figure 6A).
Surprisingly, the 2.7 A ˚ CDR H3 model shows a more compact
interface(Figure 6B)resultingina betterinterfacescore.In this case,
the native crystal structure shows interfacial water molecules which
are poorly captured by Rosetta’s implicit solvation model.
A second failure case is the complex between neuraminidase
from influenza virus and the monoclonal antibody NC41 (1NCA
[40]). Docking with crystal structures produced a docking energy
funnel, however, none of the other methods were capable of
Figure 4. SnugDock conformational diversity. (A) The diversity in
conformation generated by SnugDock during docking of anti-HEL Fab
fragment (1BQL) to bobwhite quail lysozyme (1DKJ). (B) View facing the
paratope. Crystal structure, red; heavy andthelight chains, blueand yellow,
respectively; light and heavy chain CDRs, orange and cyan, respectively;
SnugDock sampled CDR H3, grey; EnsembleDock-plus-SnugDock sampled
CDR H3, light chain CDRs and light chain framework, green, light orange
and yellow-green, respectively. Structures are all superposed onto the
heavy chain framework residues of the crystal structure. (C) Mean rmsd
from the starting structure of the ten lowest-energy docking decoys for
fifteen targets. For light and heavy chain CDRs, the corresponding
framework chain is superposed and the rmsd is queried over the respective
CDR residues. VL-VH denotes the rigid-body rmsd divergence of the heavy
chain framework when the light chain framework is superposed. The
paratope comprises all CDRs, and the rmsd was computed by superposing
the paratope and querying over the same residues. The colors of the bar
correspond to the colors of the different antibody segments in (A) and (B).
The error bars denote one standard deviation.
doi:10.1371/journal.pcbi.1000644.g004
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interface-energy decoys. The failure may be due to loop modeling
errors in regions critical for binding. The 1NCA CDR H3 loop
prediction is one of the poorest ones in our dataset: the lowest-
total-energy RosettaAntibody homology model has 3.4 A ˚ global
rmsd, and even the most native-like CDR H3 loop in the ten
lowest-total-energy homology models has a global rmsd of 2.2 A ˚.
1NCA has the longest H3 loop in our dataset (11 residues), and the
H3 loop makes key contacts with the antigen. Notably, other cases
with poor loop models dock successfully (e.g. 1VFB, 2B2X), but
typically those cases have interfaces which do not involve as many
CDR H3 contacts.
SnugDock applied to WAM antibody homology models
A longstanding source of homology models is the Web Antibody
Modeling server (WAM) created by Whitelegg and Rees [29]. The
WAM server grafts antibody components together and models the
H3 loop de novo. SnugDock may be able to compensate for the
model errors during docking. Ensemble docking is not possible
since WAM returns only one model for a given sequence. Table 2
presents the accuracy of docking predictions obtained by using
WAM antibody homology models using both standard Rosetta-
Dock and using SnugDock. The lowest-interface-energy docking
decoy generated by standard rigid-body docking simulations using
WAM homology models are almost all incorrect. Subjecting the
WAM models to SnugDock resulted in six medium quality lowest-
interface-energy docking decoys. Thus SnugDock recovers more
accurate docking predictions. The original WAM homology
models showed strain in the molecule reflected in high Rosetta
scores. By subjecting the homology model to minimization on the
paratope degrees of freedom, SnugDock was able to relieve
intramolecular and inter-chain steric clashes. Interestingly, the
Figure 5. Structural details of the monoclonal antibody Fab D44.1 complexed with lysozyme (1MLC [38]). (A) The interface region of
the lowest-energy RosettaAntibody homology model for target 1MLB complexed with the crystal structure of lysozyme (1LZA). (B) The interface
region of the most native-like prediction in the ten lowest-energy docking predictions on docking with standard rigid-body RosettaDock. (C) The
interface region of the most native-like prediction in the ten lowest-energy docking predictions on docking with SnugDock. (D) Superposition of the
structures shown in (B) and (C) viewed facing the binding region from the antigen’s side. Conformations of the antigen in the crystal structure, green;
predicted by standard rigid-body RosettaDock, red; and that predicted by SnugDock, grey; heavy and light chains, shades of blue and yellow
respectively. Sticks indicate the labeled residues that have relieved the steric clash present in the starting structure due to the flexibility allowed by
SnugDock. Transparent spheres indicate the interface region of the predicted conformation of the antigen. The light and heavy chain frameworks of
the predicted complexes are superposed on the corresponding residues of the antibody in the crystal structure.
doi:10.1371/journal.pcbi.1000644.g005
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PLoS Computational Biology | www.ploscompbiol.org 8 January 2010 | Volume 6 | Issue 1 | e1000644SnugDock results with WAM models are comparable to those with
RosettaAntibody models, while the use of EnsembleDock-plus-
SnugDock with the RosettaAntibody models achieves higher
accuracy.
Global docking
Local docking is often of interest in antibody applications since
epitope information can be obtained by a variety of other
methods. However, global docking is a computational alternative
for producing epitope information when it is unknown. Global
docking can be significantly more challenging because of the larger
conformational space to search. Further, flexible docking creates
additional danger of creating an unrealistic induced fit at a non-
native docking location, resulting in a false positive prediction
[41,42]. Global docking is considerably more computationally
demanding, and thus we restricted our tests of global docking to
five targets, and to simulate a practical docking application, chose
only those targets for which unbound crystal structures were
available for both the antibody and the antigen: 1MLC, 1AHW,
1JPS, 1WEJ and 1VFB. The starting structures consisted of the
unbound crystal structure of the antigen and the lowest-interface-
energy RosettaAntibody homology model. The EnsembleDock
and the EnsembleDock-plus-SnugDock protocols used the ten
lowest-interface-energy RosettaAntibody homology models. For
each target, we generated 5000 candidate structures, with each
prediction run beginning from a random global rotation of the
antigen and a small perturbation of the antibody (to keep the
paratope generally directed toward the antigen).
Global docking using standard rigid-body RosettaDock gener-
ated no acceptable quality lowest-interface-energy decoys for any
targets, and a top-ten ranked acceptable decoy for only one target
(Table 3). Using EnsembleDock or SnugDock independently
produced marginal improvement with a few acceptable quality
predictions. The combination algorithm of EnsembleDock-plus-
SnugDock generated two medium quality lowest-interface-energy
predictions exhibiting the synergy already established in the local
docking simulations. Additionally, the most native-like decoy in
the ten lowest-interface-energy decoys was of medium quality for
three of the five targets and acceptable for one target. The results
are comparable to global docking using standard rigid-body
RosettaDock with unbound crystal starting structures of the
antibodies, where one structure had a high quality (1JPS), two had
Figure 6. Predicted models of the complex of west Nile virus envelope protein DIII with neutralizing E16 antibody Fab (1ZTX [39]).
(A) Lowest-energy prediction (medium accuracy) generated by EnsembleDock-plus-SnugDock simulations ranked by all-atom score of the entire
complex. (B) Lowest-energy prediction (acceptable accuracy) generated by EnsembleDock-plus-SnugDock simulations ranked by the intermolecular
components of the all-atom score. The light (deep blue) and heavy (yellow) chain framework of the docked antibody is superposed on the
corresponding residues of the crystal complex. Predicted orientation of the antigen, green; light and heavy chain CDRs, orange and cyan respectively;
CDR H3 loop and antigen in the crystal structure, red; residues at the interface, transparent spheres.
doi:10.1371/journal.pcbi.1000644.g006
Table 2. Accuracy of lowest-energy docking decoy, using
WAM homology models.
Co-Crystal PDB ID
Standard
RosettaDock SnugDock
1mlc 0 **f
1ahw **f *
1jps * **
1wej 0 **
1vfb 0 **f
1bql 0 *
1k4c 0 *
2jel 0 0
1jhl 0 0
1nca 0 0
2bdn 0 *
1ynt ** **
2aep 0 **f
2b2x * *
1ztx 0 0
CAPRI Summary for Top Decoy 2**/2* 6**/5*
CAPRI Summary for Top 10 Decoys 4**/7* 1***/9**/4*
Number of Funnels 1 3
Refer to Table 1 key for explanation. Full quantitative measurements underlying
the CAPRI ratings, of the predicted models are available in Supporting
Information Table S2.
doi:10.1371/journal.pcbi.1000644.t002
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for the most native-like decoy in the ten lowest-interface-energy
decoys. The results can also be compared with local docking using
EnsembleDock-plus-SnugDock around the known epitope
(Table 1), where four of the five targets had at least a medium
quality prediction for the most native like decoy in the ten lowest-
interface-energy decoys, and the fifth target (1VFB) had an
acceptable prediction. Thus one target (1VFB) which had
succeeded in local docking failed in global docking due to low-
scoring non-native decoys (see docking energy landscapes,
Supporting Information Figure S2). In general, addition of
SnugDock increases sampling of more native-like decoys, enabling
near-natives to be energetically more favorable.
Discussion
SnugDock is the first docking algorithm with targeted antibody
flexibility. SnugDock models flexible loop conformations, back-
bone motions, and inter-chain (VH-VL) adjustments. The
introduction of flexibility during docking is critical to overcome
the inaccuracies inherent in a homology modeled antibody
structure. Comparison of algorithms shows that increasing the
degrees of freedom in local docking gradually increases the quality
of predictions. Ultimately, EnsembleDock-plus-SnugDock with
homology models achieves accuracy comparable to docking crystal
structures with standard RosettaDock. While the algorithm is
limited to antibody-antigen interactions, the results suggest that it
is possible for computational predictions to use homology models
to bridge the gap between the number of experimentally
determined complex structures and the available sequences of
pairs of interacting proteins.
In CAPRI rounds 1–18, eleven of the forty targets involved
docking of at least one homology modeled partner (both partners
were homology models for Target 35) [43–45]. For six of the
eleven targets, none of the participating groups could predict any
medium or higher accuracy structures. When the sequence
identity was under 40%, the solutions were of acceptable quality
at best (Targets 20, 24). High quality predictions were obtained
only for two cases (Targets 14, 19) and in both cases the binding
region of the template structure was structurally similar to the co-
crystal structure [44], and the other docking partner was in the
bound conformation. The poor performance of homology
modeled docking partners in CAPRI highlights the need of
docking algorithms like SnugDock which are robust to inaccura-
cies in a homology model. Targets 20 and 24 with only acceptable
predictions had poorly modeled loop and C-terminal regions
which were responsible for key contacts in the native binding
interface [45], showing that using homology models with loops
at the binding region makes docking with homology models
even harder. SnugDock with its loop relaxations at the binding
interface addresses the challenge toward accurate high-resolution
predictions.
The CDR H3 loop of antibodies provides the most diversity and
is thus a focus of the conformational sampling in the SnugDock
algorithm. In our experience with the RosettaAntibody Server
[28], there are antibodies with non-H3 loops which elude the
traditional Chothia classification system [4] and may not fit into
canonical CDR templates. The SnugDock algorithm is easily
generalizable to include perturbations of loop conformations for
any of the six CDR loops. Extra sampling however should be
restricted to special cases for efficiency and to avoid issues with
over-optimized, non-native induced-fit structures. For approach-
ing non-antibody targets, the SnugDock methods would need to
be adapted requiring knowledge of a binding site and appropriate
choices of loops to target flexibility. The multi-chain docking
methods can be applied to any multi-chain docking partner.
The flexible docking methods help in identifying the correct
docked complex structure, but unfortunately they do not yet help
in refining the monomer homology structures themselves closer to
the crystal backbone conformations. This limitation likely arises
from the vast conformational space of the backbone and the
difficulties with high-resolution refinement of protein structures
[46,47]. In docking, some of the energetic issues are avoided
through the use of the interface energy instead of the total energy.
Further advancements in refinement techniques will be needed to
address this shortcoming. SnugDock’s advancements in the
sampling problem also reveal continuing issues with the knowledge
of nature’s energy function. Missing water molecules affected the
prediction of targets 1ZTX and 1VFB. Antibody interfaces in
general are polar [48], and several targets with the most polar
interfacial CDRs (1VFB, 1JHL, 1NCA) failed perhaps due to the
challenges in modeling electrostatics [49].
Experimental techniques for epitope mapping like hydrogen-
deuterium mass spectroscopy [50] can help to pre-orient an
antigen for local docking. However, when such data are not
available, one must resort to global docking where the docking
simulations are started with random orientations of the docking
partners. Our limited testing of global docking encouragingly
suggests that the EnsembleDock-plus-SnugDock approach can
Table 3. Accuracy of global docking decoys.
Unbound
Crystal
Structures
RosettaAntibody
Homology
Model
Standard
RosettaDock
Standard
RosettaDock EnsembleDock SnugDock
EnsembleDock-
plus-SnugDock
Co-Crystal
PDB ID Top Decoy
Top 10
Decoys Top Decoy
Top 10
Decoys Top Decoy
Top 10
Decoys Top Decoy
Top 10
Decoys Top Decoy
Top 10
Decoys
1mlc 0 ** 0 0 0 0 0 0 0 *
1ahw ** ** 0 0 * * * * ** **
1jps ** *** 0 * 0 * 0 * ** **
1wej 0 * 0 0 0 0 * * 0 **
1vfb 0 * 0 0 0 0 0 0 0 0
RefertoTable1keyforexplanation.Full quantitativemeasurementsunderlyingtheCAPRIratings,ofthepredictedmodelsareavailableinSupportingInformationTableS3.
doi:10.1371/journal.pcbi.1000644.t003
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performed with care as the large conformation space can frustrate
the ability to find the native binding interface or obscure it through
false positive non-native interaction.
One could envision a complete computational antibody
engineering pipeline starting from the antibody sequence and
ending with accurate predictions for optimized antibody-antigen
interactions. In this paper we have been successful in reaching the
second step by computational docking using computational models
of the monomer antibody. The next stages may be additionally
challenging. High-resolution complex structures might next be
used for computational alanine scanning [51], computational
affinity maturation [52] or alteration of binding specificity [53].
For antibody therapeutics, structures will help define drug
mechanisms for regulatory approval [15], enable epitope mapping
[54] and humanize constructs [55]. These applications require
varying amounts of resolution and further testing will reveal the
full utility of the SnugDock predictions.
Methods
Antibody-antigen benchmark
To compare with prior work, we use the set of fifteen antibody-
antigen complexes as tested in the original RosettaAntibody
publication [27]. The antibody-antigen complex dataset was
compiled to ensure: 1) a fair representation of unbound-unbound,
unbound-bound and bound-bound antibody-antigen docking
targets, 2) a spectrum of CDR H3 loop lengths (7 to 11 residues)
and 3) both old and newly released crystal complexes (PDB release
dates 1992–2006). The RosettaAntibody and the WAM structures
are as reported previously [27].
SnugDock Protocol
SnugDock is implemented in the Rosetta biomolecular
modeling suite. Fold trees objects [24] are used to guide the
propagation of structural changes during docking with backbone
flexibility. One fold tree uses flexible jumps for moving the VL-VH
and antibody-antigen pairs relative to each other. A second fold
tree for CDR loop relaxation had fixed jumps joining the loop
stems, and cuts at the middle of the loops. Move map objects are
used to select particular sets of residues for backbone and/or side-
chain torsion angle flexibility.
Figure 1 depicts the flowchart for the steps in the SnugDock
protocol, implemented as follows. Steps 1 and 2 describe the initial
setup, Steps 3–6 describe the low resolution stage and steps 7–13
describe the high resolution stage.
1. Orient the antigen randomly:
i. Local perturbations: From a superposition of the antibody
in the bound orientation, spin antigen randomly around
the axis connecting the center of masses of the antibody
and the antigen, tilt (8u) away from the same axis and
translate (8 A ˚), similar to earlier treatments [35].
ii. Global perturbations: Randomly orient the antigen
without using any information of the antigen’s orientation
in the crystal structure. Point antibody paratope towards
antigen.
2. Slide into glancing contact as defined by at least one antibody-
antigen atomic contact within 1 A ˚ of van der Waals contact
distances.
3. Perturb the antibody by rigid-body transformations following
the low resolution phase in RosettaDock [35].
4. Optional for input comprising of an ensemble of antibody
structures: Select a structure from the ensemble of input
antibody structures by Monte Carlo swapping as described
previously [25].
5. Repeat steps 3 and 4, fifty times.
6. Optimize the CDR H2 & H3 loop conformations by small
[56], shear [56], and cyclic coordinate descent (CCD) [57]
moves and gradient-based minimization in low resolution as
detailed previously [27] except with the side chains represented
as one pseudo-atom (no side-chain packing). The fold tree [27]
is modified here to prevent the relative VL-VH movement at
coarse resolution.
7. Change representation of the protein from the low resolution to
full atomistic detail by using the side-chain conformations from
the starting antibody homology model and the unbound
antigen crystal. If the unbound crystal structure of the antigen
is not available, the antigen is packed with side-chains from a
rotamer library.
8. Optimize the side-chain conformations of the residues at the
VL-VH interface, antibody-antigen interface and all CDR loops
and neighboring residues (within 8 A ˚) by rotamer packing and
minimization including the unbound side chain conformations
as described previously [36,58].
9. Choose and apply a move from the move set. The move set
consists of five kinds of moves (the probability of each move is
indicated in percentages):
i. Rigid body perturbation of the antigen relative to the
antibody using the parameters from rigid-body pertur-
bation in the standard RosettaDock algorithm. (40%)
ii. Rigid body perturbation of the relative VL-VH orienta-
tion using the parameters from rigid-body perturbation in
the standard RosettaDock algorithm. (40%)
iii. Minimization of the backbone residues of all the CDR
loops. (10%)
iv. Relaxation of CDR H3 by small, shear and CCD moves
followed by minimization as detailed previously [27] with
the fold tree modified to prevent the relative VL-VH
movement. (5%)
v. Relaxation of CDR H2 by small, shear and CCD moves
followed by minimization as in Step 9iv. (5%)
10. Optimize selected side-chains as described in Step 8: For
rigid body perturbations (following moves 9i and 9ii), the
relevant interfacial side chains are selected for optimization.
For loop optimizations (following move 9iii), side chains of
the loop and neighboring residues are selected for
optimization.
11. Minimize selected region: Rigid body positions (following
move 9i or 9ii) or all the CDRs (following move 9iii). CDRs
H3 (move 9iv) or H2 (move 9v) are not subjected to
additional minimization.
12. Steps 9–11 are repeated fifty times and each iteration is
accepted or rejected based on a Monte Carlo criterion
(temperature, kT=0.8).
13. The lowest interface-energy structure observed during the
course of the simulation is selected as the output of the
simulation.
Each decoy of an independent docking simulation begins from a
different random starting position. In local docking, the set of
starting positions comprises a diffuse cloud that covers a
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native ligand position. In local and global docking, 1,000 and
5,000 candidate docking structures are generated for each target
respectively. In our empirical tests, 5,000 decoys were sufficient
and results were similar for test runs of 10,000 decoys in a subset of
targets. The energy function used during the course of the
simulation is as described previously [35] with (i) the interfacial
terms of the scoring function including both the antibody-antigen
interface and the VL-VH interface, and (ii) chain break penalties
for six CDR loops. Interface energy [24] is used to rank and
discriminate the structures produced by the docking simulations.
Variation in methods. Two algorithm variations we tested
require brief mention. First, incorporation of CDR H2 and H3
relaxation in low resolution generated a threefold increase in the
diversity of loop conformations than that generated by the
relaxations in full atom representation of the high resolution
alone, and improved docking accuracy. Second, early attempts at
simultaneous gradient-based minimization over all degrees of
freedom (antibody-antigen, VL-VH, non H2 & non H3 CDRs,
CDR H2, CDR H3) resulted in only small perturbations to the
relative orientation of the antibody and the antigen, while all the
other degrees of freedom remained unaltered. Better sampling was
achieved by isolating the various degrees of freedom and carrying
out multiple rounds of minimization over one randomly selected
degree of freedom while fixing the other degrees. Isolating the
degrees of freedom increased computational efficiency, and
required about one-third the time required for simultaneous
minimization.
Docking Metrics
Ligand rmsd is the deviation of the N, Ca, C and O backbone
atoms of the antigen after superposition of the antibody backbone
atoms. Interface rmsd is the deviation of the backbone atoms at
the interface after optimal superposition of those same atoms,
where the interface is defined as all residues within 10 A ˚ of a non-
hydrogen atom of the other docking partner. Interface energy is
the component of the total docking score that arises from inter-
molecular residue-residue interactions at the antibody-antigen
interface. For fnat calculations, residue-residue contacts are defined
when a residue is within 5 A ˚ of a non-hydrogen atom from the
other docking partner. The docking models are assigned CAPRI
[22]-style ‘‘high’’, ‘‘medium’’, ‘‘acceptable’’ or ‘‘incorrect’’ rank-
ings that depend on the rmsd-to-native of the ligand position, the
interface rmsd to native and the fraction of native residue-residue
contacts (fnat) that are recovered in the docked model [59].
Convergence of a docking simulation is indicated by the presence
of a docking funnel, which is defined to exist if there are at least
five medium quality predictions in the ten lowest-energy docking
decoys.
Algorithm availability
The SnugDock method presented here is freely available for
academic and non-profit use as part of the Rosetta structure
prediction suite at www.rosettacommons.org. The distribution
includes documentation and full source code. The Rosetta version
numbers and command lines used to generate the data are
provided in Supporting Information Text S1.
Supporting Information
Figure S1 Docking perturbation plots. Each row shows the
simulation for one target denoted by the four letter PDB code at
the top of the first plot in the respective row. The columns
correspond to the different docking algorithms used: 1) Standard
rigid-body docking using RosettaDock starting with the antibody
crystal structure. 2) Standard rigid-body docking using Rosetta-
Dock. 3) Docking with VL-VH optimization. 4) Docking with VL-
VH optimization with CDR minimization and CDR H3
perturbation. 5) Docking with SnugDock (VL-VH optimization
with CDR minimization and CDR H3+H2 perturbations). 6)
Rigid-body docking using EnsembleDock with the ten lowest-
energy RosettaAntibody models. 7) Docking using a combined
protocol incorporating EnsembleDock and SnugDock with the ten
lowest-energy RosettaAntibody models. Refer to Figure 2 legend
for explanation of colored points.
Found at: doi:10.1371/journal.pcbi.1000644.s001 (6.97 MB EPS)
Figure S2 Global docking plots. The four letter PDB code at the
top of each column indicates the target for which simulations were
executed for the respective column. The rows correspond to the
different docking algorithms used: 1) Standard rigid body docking
using RosettaDock. 2) EnsembleDock 3) SnugDock 4) Ensem-
bleDock-plus-SnugDock. Refer to Figure 2 legend for explanation
of colored points.
Found at: doi:10.1371/journal.pcbi.1000644.s002 (1.35 MB TIF)
Table S1 Quantitative accuracy measures of lowest-energy
docking decoy for different docking protocols. Refer to Table 1
key for explanation.
Found at: doi:10.1371/journal.pcbi.1000644.s003 (0.03 MB XLS)
Table S2 Quantitative accuracy measures of lowest-energy
docking decoy, using WAM homology models. Refer to Table 1
key for explanation.
Found at: doi:10.1371/journal.pcbi.1000644.s004 (0.03 MB XLS)
Table S3 Quantitative accuracy measures of global docking
decoys. Refer to Table 1 key for explanation.
Found at: doi:10.1371/journal.pcbi.1000644.s005 (0.03 MB XLS)
Text S1 Rosetta Version Numbers and Command Lines
Found at: doi:10.1371/journal.pcbi.1000644.s006 (0.03 MB
DOC)
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